TPST
$TPST
Tempest Therapeutics, Inc.
Clinical-stage biotech exploring cannabinoid-related therapeutics for oncology.
Cannabis$2.16
+0.00 (+0.00%)
Day Range$2.16 - $2.29
Prev Close$2.16
Analyst Rating
Strong Buy
6 Buy / 1 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
Sun, Mar 22
Weekly updates
Latest Report
TPST: Clinical Catalysts vs Cash Runway
TPST is trading at low single digits while advancing a mix of oncology programs and manufacturing partnerships. Analysts are bullish, but cash constraints and dilution are key risks to monitor.
Mar 16, 2026